Back to search

Article

The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation

2022-02-13

Abstract excerpt

<h4>Aims: </h4>: This study aimed to analyze associations between genetic variants and plasma concentrations along with clinical outcomes in dabigatran in patients with non-valvular atrial fibrillation (NVAF). <h4>Methods:</h4> We conducted a prospective study and enrolled NVAF patients treated with dabigatran in the real world. A total of 86 patients treated with 110 mg DE twice daily were recruited for this stud...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7341e4b9-4472-51c0-85e4-c7b81be5c2f8
DOI
10.22541/au.164475230.08047039/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillationDOI 10.22541/au.164475230.08047039/v1
Select a neighboring publication to make it the new centre.